|
Biotech
> Versartis ($VSAR) names Jay Shepard as president and CEO. Release
> Ziopharm Oncology ($ZIOP) appoints Dr. Laurence Cooper as CEO. Release
> Applied Proteomics names Erwin Estigarribia as vice president of commercial operations. Release
> Synthetic Biologics ($SYN) names Maureen Early as vice president, commercial. Release
> Dr. David Bernstein joins Paion as medical adviser and nonexecutive director. Release
> Foamix Pharma ($FOMX) adds Aaron Schwartz to its board of directors. Release
> Tiziana Life Sciences' CFO Phil Boyd has resigned. Release
> Oxford BioMedica adds Daniel Soland as nonexecutive director to the board. Release
> Kiadis Pharma appoints Dr. Vincent Brichard to its supervisory board. Release
> Aerie ($AERI) adds Richard Croarkin to its board of directors. Release
> NeuralStem appoints Jonathan Lloyd Jones as chief financial officer. Release
> Oxis Biotech adds Dr. Cassian Yee to its scientific advisory board. Release
> ZS Pharma ($ZSPH) adds Kimberly Popovits to its board of directors. Release
> Advaxis ($ADXS) names Thomas Hare as vice president, clinical operations. Release
> Autolus appoints John Berriman and Kapil Dhingra to its board of directors. Release
> InMed ($IMLFF) adds Peter Mountford as strategic adviser. Release
> Tocagen adds Dr. David Parkinson to its board of directors. Release
> Neurocrine Biosciences appointed Bill Aurora as its vice president of medical affairs. Release
> Immunomic Therapeutics named Eric Winzer its chief financial officer. Release
> Genovis vice president Fredrik Olsson moved up to be the company's CEO. Release
> Steven Shallcross joined Synthetic Biologics as the company's chief financial officer. Release
> Intarcia brought on James Brady as its vice president of human resources. The company also named Michael Williams its COO. Release | Release
> Trevena appointed Carrie Bourdow as its chief commercial officer. Release
> Ciclofilin Pharmaceuticals named Michael Kamdar as its president. Release
> Macrocure hired Lewis Gryziewicz as its vice president of regulatory affairs. Release
> Acucela's founder, Ryo Kubota, regained his spot as the company's CEO. Release
> Anggie Becorest joined ALT as its senior vice president of business development. Release
> Clyde Higgs took on the executive vice president position in charge of operations and business development at Castle & Cooke. Release
> Theorem Clinical Research brought on Scott Treiber to head its biopharmaceutical development. Release
> OMEICOS appointed Ulrich Dauer as its CEO. Release
> Canon U.S. Life Sciences brought on Akiko Tanaka as president and CEO. Release
Vaccines
> Immunomic Therapeutics appoints Louise Peltier as vice president of regulatory affairs. Release
CRO
> Profil Institute for Clinical Research appoints Dr. Michael Trautmann as senior director of drug development services and Dr. Gordon Brandt as senior director of clinical development and regulatory affairs. Release
> Catalent ($CTLT) adds Gregory Lucier to its board of directors. Release
Drug Delivery
> ARx promotes Tadgh Prendeville to general manager. Release
> Impax ($IPXL) named Donna Hughes a senior vice president of human resources and Deborah Penza a senior vice president and chief compliance officer. Release
Pharma Marketing
> Jane Horvath joined 3D Communications to lead its program on market access and reimbursement communications services. Release
|
